CIK 0001857044 · Non-accelerated filer<br>Smaller reporting company
Indaptus Therapeutics, Inc.
Sign in to watch- Ticker
- INDP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863158720
- Phone
- (646) 427-2727
- Business address
- 3 COLUMBUS CIRCLE, 15TH FLOOR, NEW YORK, NY, 10019
- Former names
- Intec Parent Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-08-04 | Karah Hila Director | Grant or award · Stock Option (right to buy) | +13,750 | 13,750 | ||
| 2021-08-04 | Lee Hoonmo Director | Grant or award · Stock Option (right to buy) | +13,750 | 13,750 | ||
| 2021-08-04 | Sassi Nir Chief Financial Officer | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2021-08-04 | Hayes William B Director | Grant or award · Stock Option (right to buy) | +13,750 | 13,750 | ||
| 2021-08-04 | Newman Michael James CSO and Director | Grant or award · Stock Option (right to buy) | +290,000 | 290,000 | ||
| 2021-08-04 | O'CALLAGHAN BRIAN Director | Grant or award · Stock Option (right to buy) | +13,750 | 13,750 | ||
| 2021-08-04 | MADDALUNA ANTHONY J Director | Grant or award · Stock Option (right to buy) | +13,750 | 13,750 |
Page 7 of 7 · 127 trades